• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    TriSalus Life Sciences, Inc. - Common Stock (NQ:TLSI)

    5.730 +0.080 (+1.42%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 25, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 19,512
    Open 5.660
    Bid (Size) 5.680 (3)
    Ask (Size) 5.780 (3)
    Prev. Close 5.650
    Today's Range 5.530 - 5.775
    52wk Range 3.500 - 10.24
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    TriSalus Life Sciences’ Q4 Loss Exceeds Projections, Revenue Tops Estimates – Retail Stays Pessimistic
    The company reaffirmed its previous guidance for 2025 and said it expects sales growth of over 50% and its gross margin to exceed 87%, higher than the 86% reported for 2024. 
    Via Stocktwits
    TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update
    From TriSalus Life Sciences
    Via Business Wire

    Performance

    YTD
    +15.1%
    +15.1%
    1 Month
    +1.4%
    +1.4%
    3 Month
    +11.0%
    +11.0%
    6 Month
    +39.4%
    +39.4%
    1 Year
    -44.0%
    -44.0%

    More News

    Read More
    Examining the Future: TriSalus Life Sciences's Earnings Outlook
    Via Benzinga
    TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System Mapping
    From TriSalus Life Sciences
    Via Business Wire
    A Look Ahead: TriSalus Life Sciences's Earnings Forecast
    Via Benzinga
    Earnings Scheduled For March 27, 2025
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    TriSalus Life Sciences® Announces That Its Researchers Received Two JVIR Top Paper Awards for the Publication of “Intra-arterial Pressure-Enabled Drug Delivery™ Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model”
    From TriSalus Life Sciences
    Via Business Wire
    3 Stocks With Robust Growth Outlooks Insiders Are Buying
    Via MarketBeat
    TriSalus Life Sciences Announces Key Appointments to Board of Directors
    From TriSalus Life Sciences
    Via Business Wire
    TriSalus Life Sciences Announces Drawdown of $10 Million Tranche Under Credit Agreement with OrbiMed
    From TriSalus Life Sciences
    Via Business Wire
    TriSalus Life Sciences Announces Preliminary Q4 and Full Year Unaudited 2024 Financial Results and Conference Call
    From TriSalus Life Sciences
    Via Business Wire
    TriSalus Life Sciences® Announces Publication of Pre-Clinical Data Demonstrating Improved Delivery of Embospheres® to Liver Tumors using Pressure-Enabled Drug Delivery™ (PEDD™) via the TriNav® Infusion System
    From TriSalus Life Sciences
    Via Business Wire
    TriSalus Announces Leadership Changes
    From TriSalus Life Sciences
    Via Business Wire
    TriSalus Reports Q3 2024 Financial Results and Provides Business Update
    From TriSalus Life Sciences
    Via Business Wire
    This GeoVax Labs Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Monday
    Via Benzinga
    TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer
    From TriSalus Life Sciences
    Via Business Wire
    Earnings Scheduled For November 14, 2024
    Via Benzinga
    TriSalus Life Sciences Launches TriNav® LV Infusion System and TriGuide™ Guiding Catheters, Expanding Portfolio of PEDD™ Devices for Improved Tumor Treatment
    From TriSalus Life Sciences
    Via Business Wire
    TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call
    From TriSalus Life Sciences
    Via Business Wire
    TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
    From TriSalus Life Sciences
    Via Business Wire
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    TriSalus Life Sciences Announces Appointment of Riad Salem, M.D., to its Scientific Advisory Board
    From TriSalus Life Sciences
    Via Business Wire
    TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion System
    From TriSalus Life Sciences
    Via Business Wire
    TLSI Stock Earnings: TriSalus Life Sciences Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace

    Frequently Asked Questions

    Is TriSalus Life Sciences, Inc. - Common Stock publicly traded?
    Yes, TriSalus Life Sciences, Inc. - Common Stock is publicly traded.
    What exchange does TriSalus Life Sciences, Inc. - Common Stock trade on?
    TriSalus Life Sciences, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for TriSalus Life Sciences, Inc. - Common Stock?
    The ticker symbol for TriSalus Life Sciences, Inc. - Common Stock is TLSI on the Nasdaq Stock Market
    What is the current price of TriSalus Life Sciences, Inc. - Common Stock?
    The current price of TriSalus Life Sciences, Inc. - Common Stock is 5.730
    When was TriSalus Life Sciences, Inc. - Common Stock last traded?
    The last trade of TriSalus Life Sciences, Inc. - Common Stock was at 04/25/25 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.